Moreover, Sun et al. (2019) reported that cotreatment with S11—which simultaneously inhibits HDACs and P-glycoprotein (P-gp)—and cisplatin suppressed colony formation and blocked the migration of cisplatin-resistant NSCLC cells [40]. This evidence concerns the gene ABCB1 and non-small cell lung carcinoma.